The Buzz: Leukemia Patient Blames Animal Research

In an opinion piece published in the Huffington Post Wednesday, a woman dying of leukemia vehemently spoke out against animal testing in medicine, positing that scientists might have found a cure for her condition by now if "they weren't sidetracked by misleading animal tests." While acknowledging the unfortunate nature of the woman's situation, ScienceBloggers are criticizing her stance that animal trials are not beneficial or are somehow to blame for the woman's sickness, asserting the necessity of using animal models for drug research and reinforcing that researchers must proceed in ways that minimize the suffering of even the tiniest of subjects. "[She] should not be allowed to use her own impending death to falsely claim the role of a martyr to animal rights research, a martyr whose life would have been saved if it weren't for [the] animal researchers who are... ironically enough, trying to find ways to save the lives of patients just like her," said ScienceBlogger Orac from Respectful Insolence.

Related ScienceBlogs Posts:

More like this

I'm not a regular reader of the Huffington Post, but I received a pointer to an article there that strikes me as worthy of comment. The article, Why I Take Animal-Tested Drugs, was written by Simon Chaitowitz, the former Communications director for the animal rights group Physicians Committee for…
With all the talk about the theory regarding animal rights, AR activism, animal research and terroristic attacks on scientists, this bit of news in the aftermath of the recent California firebombing may have been missed: Law enforcement officers Thursday raided the same Riverside Avenue house that…
So there's a Behavioral and Brain Sciences paper in press on the cognitive differences between human and nonhuman animals that is related, in some ways, to my own work (it even cites me twice... yay, the citation count for that paper just jumped to, like, 4). The paper is sure to be controversial…
A federal appeals court has denied the right of patients to the use of cancer drugs prior to their complete assessment of safety and efficacy. The case was filed against the US FDA in 2003 by the Abigail Alliance for Better Access to Developmental Drugs, who argued that patients have a…